PureTech Health’s Vedanta Biosciences has appointed Susan Dillon as an independent member to its Board of Directors. Susan previously served as global therapeutic area head for immunology at Janssen Research & Development. She is currently co-founder, president and CEO of Aro Biotherapeutics, a biotechnology company focused on next generation protein medicines. She serves on the Board of Directors of the Wistar Institute and is an advisor to the DMAX Foundation which is focused on mental health.
